Wolfgang Miesbach: A Hidden Platelet Activation State Bridging Thrombosis and Inflammation
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Rainer Kaiser and Leo Nicolai, published in Nature Reviews Cardiology:
”Procoagulant Platelets in Cardiovascular Thrombosis (Nature Portfolio Reviews Cardiology).
This comprehensive review by Rainer Kaiser and Leo Nicolai from the University Hospital Ludwig-Maximilian University in Munich, Germany and DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V. examines a hidden platelet activation state that bridges thrombosis and inflammation across arterial clots, venous thromboembolism, stroke, and immune-driven diseases.
Beyond Classical Platelet Aggregation
Most think of platelets as simple clot-formers. But they adopt a second identity—procoagulant platelets—that directly generate thrombin.
What’s Different?
Under extreme activation (thrombin + collagen + high shear stress), platelets transform: membrane flipping exposes phosphatidylserine, creating a landing pad for coagulation factors. The platelet becomes a coagulation factory.
Clinical Relevance
Elevated in coronary artery disease, deep vein thrombosis, ischemic stroke
Drive immune-mediated thrombosis in COVID-19 severity, VITT, HIT
Shared FcγRIIA activation mechanism across immune diseases.
Why Aspirin and Current Drugs Fail
Aspirin and anticoagulants bypass this pathway entirely. This activation requires sustained calcium surges and mitochondrial permeability transition—distinct from classical aggregation targets. They cannot stop the mitochondrial cascade that powers procoagulant transformation.
Therapeutic Opportunity
Selective inhibition (cyclophilin D, TMEM16F, aquaporin-1) reduces thrombosis with minimal bleeding—unlike broad antiplatelet approaches. Selectively target pathological hyperactivation while preserving protective hemostasis. Beyond aspirin.
Title: Procoagulant platelets: linking coagulation and thromboinflammation in cardiovascular disease
Authors: Rainer Kaiser, Leo Nicolai
Read the Full Article on Nature Reviews Cardiology.
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’